Agios Pharmaceuticals Inc (NASDAQ:AGIO)

94.30
Delayed Data
As of Mar 31
 -4.50 / -4.55%
Today’s Change
31.42
Today|||52-Week Range
138.85
-15.83%
Year-to-Date

Today’s Trading

Previous close98.80
Today’s open98.61
Day’s range-- - --
Volume420,489
Average volume (3 months)683,714
Market cap$3.5B
Dividend yield--
Data as of 03/31/2015

Growth & Valuation

Earnings growth (last year)+43.82%
Earnings growth (this year)-83.99%
Earnings growth (next 5 years)--
Revenue growth (last year)+155.82%
P/E ratioNM
Price/Sales57.71
Price/Book8.24

Competitors

 Today’s
change
Today’s
% change
EXAMExamWorks Group Inc+0.01+0.02%
GNMKGenMark Diagnostics ...-0.32-2.41%
NVTAInvitae Corp-0.34-1.99%
RDNTRadNet Inc-0.08-0.94%
Data as of 03/31/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.91
Annual revenue (last year)$65.4M
Annual profit (last year)-$53.5M
Net profit margin-81.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David Paul Schenkein
Chief Operating Officer
John Duncan Higgons
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account